Isosilybin

• Description:

  Isosilybin and Silybin might be suitable candidates to design potent PXR antagonists to prevent drug-drug interactions via CYP3A4 in cancer patients.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  482.44

• Molecular Formula:

  C25H22O10

• Notes:

  Research use only, not for human use.

• Receptor:

  CYP3A4

• CAS Number:

  72581-71-6